Search
Zhiran Medical, a pioneering company specializing in invasive brain-computer interface technology, has successfully concluded a fresh round of funding, amassing more than 600 million yuan. This investment round attracted a diverse group of investors, including Shunxi Fund, Jefeng Capital, Legend Capital, Sequoia Capital China (specifying "China" for cultural precision, as Sequoia operates globally with regional branches), China Life Capital, YuanSheng Capital, Shunwei Capital, Meituan Longzhu, Zhongguancun Science City, Xingze Capital, Jiayin Capital, CAS Star, Huagai Capital, and Danlu Capital. Public records indicate that, following its Series A funding round of over 300 million yuan in August of the previous year, Zhiran Medical's total funding has now surpassed 1.2 billion yuan, marking a significant milestone in its growth trajectory.
-
C114 Communication Network -
Communication Home
